A long-term survivor with pulmonary large-cell neuroendocrine carcinoma.
Pulmonary large-cell neuroendocrine carcinoma (LCNEC) has been characterized by highly aggressive behavior, with early spread to both regional lymph nodes and distant sites and a rapidly fatal course. In fact, no reports have described an advanced pulmonary LCNEC patient who has had long-term survival. A patient with large-sized pulmonary LCNEC, who is free of disease 11 years after surgery and postoperative chemotherapy, was reported.
Ohara
Gen
G
Division of Respiratory Medicine, Institute of Clinical Medicine, University of Tsukuba, Tsukuba-city, Ibaraki 305-8575, Japan.
Satoh
Hiroaki
H
Kikuchi
Norihiro
N
Iijima
Tatsuo
T
Ohtsuka
Morio
M
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D018287:Carcinoma, Large Cell / Q000000981:diagnostic imaging / Q000628:therapy*; D018278:Carcinoma, Neuroendocrine / Q000000981:diagnostic imaging / Q000628:therapy*; D003131:Combined Modality Therapy; D018572:Disease-Free Survival; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011859:Radiography
D000970:Antineoplastic Agents